Company Overview
Vitazi.ai is leading the field of Oculomics, building next-generation solutions that enable early disease interception at population scale.
Our Vision
We are revolutionizing disease detection with point-of-care vital health evaluations powered by Oculomics.
The eye is more than a window to vision—it’s a window to the body. The retina is a direct extension of the brain and contains a dense network of vessels and nerves highly sensitive to systemic changes. These subtle changes often reveal early warning signs of diseases long before symptoms appear elsewhere.
By unlocking the retina, we enable a proactive shift from reactive treatment to early intervention.
Where We Operate
Vitazi sits at the convergence of MedTech and HealthTech, delivering a turnkey platform that integrates seamlessly into existing care settings.
- Vitazi Insights™ – A cloud-native SaaS platform that transforms any retinal camera into a powerful health evaluation tool. Insights integrates seamlessly with EHRs and optometry workflows, delivering rapid, AI-assisted reports that enhance provider decision-making.
- Vitazi-MD™ – Our telehealth solution, empowering providers with remote retinal evaluations.
- Vitazi-DR™ – Our autonomous solution, currently in U.S. clinical trials and already deployed in Mexico.
Our platform extends far beyond diabetic retinopathy—opening the door to early interception of cardiovascular, neurologic, and metabolic disease.
Scalable Deployment
Vitazi can be installed directly into:
- Primary care practices
- Clinical lab testing sites
- Retail pharmacy clinics
- Integrated health systems
This model increases access, improves compliance, and reduces overall disease burden through earlier detection and intervention.
Why Providers Choose Vitazi
Our solution offers clear benefits:
- Seamless integration into existing workflows
- No upfront costs or IT burden
- New revenue opportunities for practices
- Reduced provider workload while enhancing patient care
Market Opportunity & Financial Projections
DR Evaluation Market
$B
Prediabetic and diabetic
US total addressable market
$B
Type 2 Diabetes
US serviceable addressable market currently diagnosed diabetic
$M
US Vitazi.ai’s obtainable market
25% of market share due to unique solution

Diabetes Is only Our First Application.
It is only scratching the surface because the eye is a window to a person’s overall health. Several other eye, cardiovascular, and neurological diseases can cause changes in the eye which can be detected by oculomics through imaging and measurement techniques.
Oculomics Market
We’re focusing on Oculomics.
Not only is Oculomics projected to significantly grow, but AI in healthcare is also estimated to grow over 1,400% by 2029.
$B
2021
$B
2028